|

Montelukast Clinical Trials

6 actively recruiting trials across 4 locations

No change since May 2026

Also known as: Singulair

Pipeline

Early 1: 1Phase 2: 1Phase 3: 2Phase 4: 2

Top Sponsors

  • University of Colorado, Denver1
  • Sherief Abd-Elsalam1
  • Shanghai Zhongshan Hospital1
  • Emory University1
  • Benjamin T Diamond, MD1

Indications

Other2 trials

Effect of Some Drugs on Rheumatoid Arithritis Activity
Phase 3
Efficacy of Montelukast on STEMl Patients
Phase 3

Aurora, Colorado1 trial

Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes

University of Colorado Anschutz Medical Campus

Phase 4

Miami, Florida1 trial

Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma

University of Miami

Phase 2

Atlanta, Georgia1 trial

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University Hospital/Winship Cancer Institute

Phase 4

Lexington, Kentucky1 trial

MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)

UK Healthcare at Turfland

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.